OBJECTIVE: To study the effects of an acute therapeutic oral intake of beta(2) agonist on performance and substrate response during supramaximal exercise in women. METHODS:12 healthy moderately trained female volunteers performed a Wingate test after ingestion of placebo (Pla) and salbutamol (Sal; 4 mg) according to a double-blind randomised crossover study. Blood samples were collected at rest, at the end of exercise and after 5 (r5), 10 (r10) and 15 (r15) min of passive recovery for adrenocorticotropic hormone (ACTH), growth hormone (GH), insulin, blood glucose and lactate measurements. RESULTS:Peak power (PP) and mean power (MP) significantly increased whereas time to peak power was significantly shorter with Sal than with Pla (p<0.05). No change was observed in the fatigue index. ACTH was not significantly modified but r15 growth hormone significantly decreased (p<0.05) after the intake of Sal. Both blood INS and blood glucose were significantly increased by the intake of Sal during all the experiments (p<0.01). Blood lactate was significantly increased by the intake of Sal compared with that of Pla (p<0.05) after 10 and 15 min of passive recovery. CONCLUSION: From these data, acute therapeutic oral intake of Sal seems to induce, irrespective of the subjects' gender, an improvement in performance during a supramaximal exercise--that is, increase in PP and MP. Further studies are necessary to clarify whether the mechanisms involved in the response to intake of Sal are linked to central and/or peripheral pathways.
RCT Entities:
OBJECTIVE: To study the effects of an acute therapeutic oral intake of beta(2) agonist on performance and substrate response during supramaximal exercise in women. METHODS: 12 healthy moderately trained female volunteers performed a Wingate test after ingestion of placebo (Pla) and salbutamol (Sal; 4 mg) according to a double-blind randomised crossover study. Blood samples were collected at rest, at the end of exercise and after 5 (r5), 10 (r10) and 15 (r15) min of passive recovery for adrenocorticotropic hormone (ACTH), growth hormone (GH), insulin, blood glucose and lactate measurements. RESULTS: Peak power (PP) and mean power (MP) significantly increased whereas time to peak power was significantly shorter with Sal than with Pla (p<0.05). No change was observed in the fatigue index. ACTH was not significantly modified but r15 growth hormone significantly decreased (p<0.05) after the intake of Sal. Both blood INS and blood glucose were significantly increased by the intake of Sal during all the experiments (p<0.01). Blood lactate was significantly increased by the intake of Sal compared with that of Pla (p<0.05) after 10 and 15 min of passive recovery. CONCLUSION: From these data, acute therapeutic oral intake of Sal seems to induce, irrespective of the subjects' gender, an improvement in performance during a supramaximal exercise--that is, increase in PP and MP. Further studies are necessary to clarify whether the mechanisms involved in the response to intake of Sal are linked to central and/or peripheral pathways.
Authors: Babette M Pluim; Olivier de Hon; J Bart Staal; Jacqueline Limpens; Harm Kuipers; Shelley E Overbeek; Aeilko H Zwinderman; Rob J P M Scholten Journal: Sports Med Date: 2011-01-01 Impact factor: 11.136
Authors: Andreas Breenfeldt Andersen; Glenn A Jacobson; Jacob Bejder; Dino Premilovac; Stephen M Richards; Jon J Rasmussen; Søren Jessen; Morten Hostrup Journal: Sports Med Date: 2021-04-02 Impact factor: 11.136
Authors: Anna C Z Rodrigues; Maria L Messi; Zhong-Min Wang; Martin C Abba; Andrea Pereyra; Alexander Birbrair; Tan Zhang; Meaghan O'Meara; Ping Kwan; Elsa I S Lopez; Monte S Willis; Akiva Mintz; D Clark Files; Cristina Furdui; Ronald W Oppenheim; Osvaldo Delbono Journal: Acta Physiol (Oxf) Date: 2018-10-22 Impact factor: 6.311
Authors: Muath M Altarawneh; Aaron Petersen; Robert Smith; David M Rouffet; Francois Billaut; Ben D Perry; Victoria L Wyckelsma; Antony Tobin; Michael J McKenna Journal: Eur J Appl Physiol Date: 2016-10-22 Impact factor: 3.078
Authors: S P Beloka; C Janssen; E Woff; E Brassine; G Deboeck; J Randria; V Philippart de Foy; P van de Borne; R Naeije Journal: Eur J Appl Physiol Date: 2011-02-16 Impact factor: 3.078
Authors: A Arlettaz; B Le Panse; H Portier; A-M Lecoq; R Thomasson; J De Ceaurriz; K Collomp Journal: Eur J Appl Physiol Date: 2008-10-17 Impact factor: 3.078